ACCELERON PHARMA INC (26)

Browse by Contract Category

Contracts

Amendment to the Employment Agreement between Adam Veness and Acceleron Pharma Inc., dated as of September 29, 2021 (Filed With SEC on November 4, 2021)
Agreement and Plan of Merger, dated as of September 29, 2021, by and among Acceleron Pharma Inc., Merck Sharp & Dohme Corp. and Astros Merger Sub, Inc (Filed With SEC on September 30, 2021)
Collaboration, License and Option Agreement between Acceleron Pharma Inc. and Celgene Corporation, dated as of August 2, 2011 (Filed With SEC on August 5, 2021)
Offer Letter between Jay T. Backstrom, M.D., M.P.H. and Acceleron Pharma Inc., dated as of December 4, 2019 (Filed With SEC on February 25, 2021)
Underwriting Agreement, dated June 30, 2020, by and among the Company and the Representatives (Filed With SEC on July 2, 2020)
Amendment to the Employment Agreement between Kevin McLaughlin and Acceleron Pharma Inc., dated as of September 29, 2021 (Filed With SEC on November 4, 2021)
Amendment to the Employment Agreement between Sujay Kango and Acceleron Pharma Inc., dated as of September 29, 2021 (Filed With SEC on November 4, 2021)
Amendment to the Employment Agreement between Jay Backstrom and Acceleron Pharma Inc., dated as of September 29, 2021 (Filed With SEC on November 4, 2021)
Amendment to the Employment Agreement between Habib Dable and Acceleron Pharma Inc., dated as of September 29, 2021 (Filed With SEC on November 4, 2021)
Form of Non-Statutory Stock Option Agreement for Company Employees under the 2013 Equity Incentive Plan (Filed With SEC on February 25, 2021)
Form of Performance-Based Restricted Stock Unit Award Agreement under the 2013 Equity Incentive Plan (Filed With SEC on February 25, 2021)
Form of Restricted Stock Unit Award Agreement for Non-Employee Directors under the 2013 Equity Incentive Plan (Filed With SEC on February 25, 2021)
Form of Restricted Stock Unit Award Agreement for Company Employees under the 2013 Equity Incentive Plan (Filed With SEC on February 25, 2021)
Form of Non-Statutory Stock Option Agreement for Non-Employee Directors under the 2013 Equity Incentive Plan (Filed With SEC on February 25, 2021)
Employment Agreement between Jay T. Backstrom, M.D., M.P.H. and Acceleron Pharma Inc., dated as of December 10, 2019 (Filed With SEC on February 25, 2021)
Employment Agreement between Adam M. Veness, Esq. and Acceleron Pharma Inc., dated as of June 5, 2019 (Filed With SEC on February 25, 2021)
Letter Agreement to Amended and Restated Collaboration, License and Option Agreement between Acceleron Pharma Inc. and Celgene Corporation, dated as of March 10, 2020 (Filed With SEC on May 11, 2020)
Form of Performance-Based Restricted Stock Unit Award Agreement under the 2013 Equity Incentive Plan (Filed With SEC on February 27, 2020)
Form of Restricted Stock Unit Award Agreement under the 2013 Equity Incentive Plan (Filed With SEC on February 27, 2020)
Form of Non-Statutory Stock Option Agreement under the 2013 Equity Incentive Plan (Filed With SEC on February 27, 2020)
Description of Capital Stock (Filed With SEC on February 27, 2020)
Employment Agreement between Sujay Kango and Acceleron Pharma Inc., dated as of February 12, 2018 (Filed With SEC on February 27, 2019)
Employment Agreement between Robert K. Zeldin and Acceleron Pharma Inc., dated as of June 29, 2018 (Filed With SEC on February 27, 2019)
Offer Letter between Robert K. Zeldin and Acceleron Pharma Inc., dated as of June 15, 2018 (Filed With SEC on February 27, 2019)
Offer Letter between Sujay Kango and Acceleron Pharma Inc., dated as of December 29, 2017 (Filed With SEC on February 27, 2019)
Underwriting Agreement, dated January 15, 2019, by and among the Company and the Representatives (Filed With SEC on January 17, 2019)